Assessment of insulin secretion is potentially helpful in clinical practice: differences in glycaemic treatment requirements between Type 1 and Type 2 diabetes mainly relate to the development of absolute insulin deficiency in the former. The gene discussed is INS; the disease is type 2 diabetes mellitus.